Biogen MS Drug Delays RelapsesStreet.Com - Biogen Idec ( BIIB :Nasdaq - news - research - Cramer’s Take ) said its drug Avonex delayed the development of multiple sclerosis for up to five years in patients treated immediately after their first MS attack, according to recently published trial
Read The Full Article:
http://www.drilltools.org/304
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!
Powered by blogdig.net